
ARQQ Valuation
Arqit Quantum Inc
- Overview
- Forecast
- Valuation
- Earnings
ARQQ Relative Valuation
ARQQ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARQQ is overvalued; if below, it's undervalued.
Historical Valuation
Arqit Quantum Inc (ARQQ) is now in the Overvalued zone, suggesting that its current forward PS ratio of 122.25 is considered Overvalued compared with the five-year average of -24.97. The fair price of Arqit Quantum Inc (ARQQ) is between 3.94 to 23.65 according to relative valuation methord. Compared to the current price of 31.51 USD , Arqit Quantum Inc is Overvalued By 33.25%.
Relative Value
Fair Zone
3.94-23.65
Current Price:31.51
33.25%
Overvalued
-12.59
PE
1Y
3Y
5Y
Trailing
Forward
-14.01
EV/EBITDA
Arqit Quantum Inc. (ARQQ) has a current EV/EBITDA of -14.01. The 5-year average EV/EBITDA is 11.68. The thresholds are as follows: Strongly Undervalued below -208.33, Undervalued between -208.33 and -98.33, Fairly Valued between 121.69 and -98.33, Overvalued between 121.69 and 231.70, and Strongly Overvalued above 231.70. The current Forward EV/EBITDA of -14.01 falls within the Historic Trend Line -Fairly Valued range.
-14.01
EV/EBIT
Arqit Quantum Inc. (ARQQ) has a current EV/EBIT of -14.01. The 5-year average EV/EBIT is -5.66. The thresholds are as follows: Strongly Undervalued below -117.93, Undervalued between -117.93 and -61.80, Fairly Valued between 50.48 and -61.80, Overvalued between 50.48 and 106.62, and Strongly Overvalued above 106.62. The current Forward EV/EBIT of -14.01 falls within the Historic Trend Line -Fairly Valued range.
122.25
PS
Arqit Quantum Inc. (ARQQ) has a current PS of 122.25. The 5-year average PS is 38.89. The thresholds are as follows: Strongly Undervalued below -53.23, Undervalued between -53.23 and -7.17, Fairly Valued between 84.95 and -7.17, Overvalued between 84.95 and 131.01, and Strongly Overvalued above 131.01. The current Forward PS of 122.25 falls within the Overvalued range.
0.00
P/OCF
Arqit Quantum Inc. (ARQQ) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.46. The thresholds are as follows: Strongly Undervalued below -134.66, Undervalued between -134.66 and -70.56, Fairly Valued between 57.63 and -70.56, Overvalued between 57.63 and 121.73, and Strongly Overvalued above 121.73. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Arqit Quantum Inc. (ARQQ) has a current P/FCF of 0.00. The 5-year average P/FCF is -9.91. The thresholds are as follows: Strongly Undervalued below -43.25, Undervalued between -43.25 and -26.58, Fairly Valued between 6.75 and -26.58, Overvalued between 6.75 and 23.42, and Strongly Overvalued above 23.42. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Arqit Quantum Inc (ARQQ) has a current Price-to-Book (P/B) ratio of 25.99. Compared to its 3-year average P/B ratio of 8.63 , the current P/B ratio is approximately 201.01% higher. Relative to its 5-year average P/B ratio of 47.00, the current P/B ratio is about -44.70% higher. Arqit Quantum Inc (ARQQ) has a Forward Free Cash Flow (FCF) yield of approximately -5.77%. Compared to its 3-year average FCF yield of -30.87%, the current FCF yield is approximately -81.30% lower. Relative to its 5-year average FCF yield of -23.83% , the current FCF yield is about -75.77% lower.
26.02
P/B
Median3y
8.63
Median5y
47.00
-5.77
FCF Yield
Median3y
-30.87
Median5y
-23.83
Competitors Valuation Multiple
The average P/S ratio for ARQQ's competitors is 24.97, providing a benchmark for relative valuation. Arqit Quantum Inc Corp (ARQQ) exhibits a P/S ratio of 122.25, which is 389.65% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ARQQ increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ARQQ in the past 1 year is driven by Unknown.
People Also Watch

LWAY
Lifeway Foods Inc
30.950
USD
+1.94%

COOK
Traeger Inc
1.260
USD
-1.56%

GIG
GigCapital7 Corp
10.370
USD
+0.10%

MBX
MBX Biosciences Inc
15.370
USD
+10.66%

YSG
Yatsen Holding Ltd
9.720
USD
-1.82%

ABSI
Absci Corp
2.550
USD
+0.39%

HCAT
Health Catalyst Inc
3.500
USD
+4.79%

CERS
Cerus Corp
1.330
USD
+3.91%

NMRA
Neumora Therapeutics Inc
1.740
USD
+6.75%

TRVI
Trevi Therapeutics Inc
7.420
USD
+1.92%
FAQ

Is Arqit Quantum Inc (ARQQ) currently overvalued or undervalued?
Arqit Quantum Inc (ARQQ) is now in the Overvalued zone, suggesting that its current forward PS ratio of 122.25 is considered Overvalued compared with the five-year average of -24.97. The fair price of Arqit Quantum Inc (ARQQ) is between 3.94 to 23.65 according to relative valuation methord. Compared to the current price of 31.51 USD , Arqit Quantum Inc is Overvalued By 33.25% .

What is Arqit Quantum Inc (ARQQ) fair value?

How does ARQQ's valuation metrics compare to the industry average?

What is the current P/B ratio for Arqit Quantum Inc (ARQQ) as of Aug 27 2025?

What is the current FCF Yield for Arqit Quantum Inc (ARQQ) as of Aug 27 2025?

What is the current Forward P/E ratio for Arqit Quantum Inc (ARQQ) as of Aug 27 2025?
